John Smither Adds to GNLX Holdings with New Share Purchase

John Smither recently increased his stake in GNLX by purchasing 31,566 shares on June 16, 2026. This insider transaction adds to his existing holdings, reflecting a continued interest in the company's prospects.

Other Institutional Activity in GNLX

Several institutional investors have also been active in GNLX. Woodward Diversified Capital, LLC grew its holdings by 184,472 shares, ending with 2,117,183 shares worth about $5,906,941. Vanguard Capital Management LLC initiated a position with 1,695,480 shares valued at $4,103,062. Bleichroeder LP significantly boosted its stake by 666,666 shares to hold a total of 1,380,666 shares, valued at $3,341,212. Geode Capital Management, LLC added 72,354 shares, bringing its total to 453,761 shares valued at $1,098,677. Meanwhile, BlackRock, Inc. increased its holdings by 20,564 shares to a total of 405,872 shares, valued at $982,210.

Genelux Corporation Stock Up 4.0%

GNLX shares are trading around $2.96. The stock has seen varied interest from institutional investors, indicating a dynamic investment landscape. Details on GNLX’s market cap, P/E ratio, and other financial metrics were not provided, but the company's stock movement remains under close watch by analysts and investors alike.

Insider Buying and Selling at Genelux Corporation

In addition to John Smither's purchase, several other insiders were active on June 16, 2026. James Tyree, Mary Mirabelli, and John Thomas each bought 31,566 shares. Yong Yu, the Chief Scientific Officer, acquired 119,318 shares. These transactions were not part of any pre-planned trading programs, suggesting confidence in the company's future.

Analysts Set New Price Targets

Analysts remain optimistic about GNLX. On March 20, 2026, Benchmark maintained its 'buy' rating with a $20 price target. This aligns with previous positive ratings, including Lake Street's initiation with a $16 target on October 21, 2025. The consensus among analysts is a 'buy' recommendation, with the average target price reflecting expected growth potential.

Bottom Line

John Smither's recent purchase of GNLX shares is part of a broader trend of insider buying, suggesting confidence in the company's future. Institutional activity also reflects varied interest, with several large funds adjusting their positions. Analysts continue to support the stock with 'buy' ratings, underlining a positive outlook. However, it's important to remember that insider and institutional trades are backward-looking and may not reflect current positions.